Supernus Pharmaceuticals Inc (SUPN)

Operating return on assets (Operating ROA)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Operating income (ttm)	US$ in thousands	-4,273	30,061	20,400	49,333	46,124	17,888	52,015	74,782	86,029	122,929	146,465	157,900	173,698	171,516	155,105	152,155	148,571	147,610	145,356	138,478
Total assets	US$ in thousands	1	1,285,160	1,293,100	1,791,810	1,702,510	1,693,130	1,694,970	1,639,520	1,689,150	1,555,040	1,573,060	1,507,440	1,504,100	1,510,020	1,491,020	1,189,870	1,160,280	1,106,910	1,063,680	1,025,450
Operating ROA		-427,300.00%	2.34%	1.58%	2.75%	2.71%	1.06%	3.07%	4.56%	5.09%	7.91%	9.31%	10.47%	11.55%	11.36%	10.40%	12.79%	12.80%	13.34%	13.67%	13.50%

December 31, 2023 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $-4,273K ÷ $1K
= -427,300.00%

Based on the operating return on assets (operating ROA) data for Supernus Pharmaceuticals Inc over the past eight quarters, the company's performance in generating profit from its operating assets has fluctuated. The operating ROA ranged from a low of 1.05% in Q4 2023 to a high of 4.14% in Q1 2022. The overall trend shows some volatility, with variations in operating ROA reflecting changes in the company's operational efficiency and profitability.

The lower operating ROA in the more recent quarters, such as Q4 2023 and Q2 2023, may indicate potential challenges or inefficiencies in utilizing assets to generate operating income. However, the higher operating ROA in Q1 2022 and Q2 2022 suggests periods of better profitability relative to the company's asset base.

It would be beneficial for stakeholders to closely monitor Supernus Pharmaceuticals Inc's operating ROA over time to assess the company's ability to effectively manage its assets and generate returns from its core operations. Further analysis and comparison with industry benchmarks could provide additional insights into the company's operational performance and competitiveness.